Clinical variables | All patients N = 131 |
---|---|
Age (years) | 72.3 ± 8.9 |
Male gender | 83 (63.3%) |
Body weight (Kg) | 61.2 ± 12.8 |
CHF | 51 (38.9%) |
Hypertension | 92 (70.2%) |
Age (> 75 years) | 57 (43.5%) |
Diabetes mellitus | 59 (45.0%) |
Stroke | 19 (14.5%) |
CHADS2 score | |
0 | 11 (8.4%) |
1 | 29 (22.1%) |
2 | 39 (29.8%) |
3 | 28 (21.4%) |
4 | 15 (11.5%) |
5 | 8 (6.1%) |
6 | 1 (0.8%) |
Vascular disease | 31 (23.7%) |
Persistent AF | 62 (47.3%) |
ACE-Is/ARBs | 55 (42.0%) |
Diuretics | 40 (30.5%) |
LAD (mm) | 43.2 ± 7.0 |
LVEF (%) | 64.1 ± 12.0 |
Baseline eGFR (mL/min/1.73 m2) | 62.5 ± 18.4 |
Baseline CKD class | |
G1 | 8 (6.1%) |
G2 | 65 (49.6%) |
G3a and 3b | 55 (42.0%) |
G4 | 3(2.3%) |